Difference between revisions of "Team:SZU China/Composite parts"
| Line 43: | Line 43: | ||
<div class="col-sm-4"> | <div class="col-sm-4"> | ||
<div class="part_name"> | <div class="part_name"> | ||
| − | <h3><strong>New Composite Part</strong> : SV40+Rluc</h3> | + | <h3><strong>New Composite Part</strong> : SV40+Rluc Composite</h3> |
</div> | </div> | ||
<div class="part_info"> | <div class="part_info"> | ||
| Line 56: | Line 56: | ||
<div class="col-sm-4"> | <div class="col-sm-4"> | ||
<div class="part_name"> | <div class="part_name"> | ||
| − | <h3>hUPⅡ+AckRS</h3> | + | <h3><strong>New Composite Part</strong> : hUPⅡ+AckRS Composite</h3> |
</div> | </div> | ||
<div class="part_info"> | <div class="part_info"> | ||
| − | <p><a href="http://parts.igem.org/Part:BBa_K1722007"> | + | <p><a href="http://parts.igem.org/Part:BBa_K1722007">BBa_K1722007</a><br> |
hUPⅡ is a bladder specific promoter that can only drive gene expression in urothelium cells. As the output gene of this recombinant plasmid, AckRS can produce an RNA synthetase which can achieve the attachment of Ack and tRNA. This composite part will perform its function together with two other plasmids (BBa_K1722010& BBa_K1722012) | hUPⅡ is a bladder specific promoter that can only drive gene expression in urothelium cells. As the output gene of this recombinant plasmid, AckRS can produce an RNA synthetase which can achieve the attachment of Ack and tRNA. This composite part will perform its function together with two other plasmids (BBa_K1722010& BBa_K1722012) | ||
</p> | </p> | ||
| Line 67: | Line 67: | ||
<div class="col-sm-4"> | <div class="col-sm-4"> | ||
<div class="part_name"> | <div class="part_name"> | ||
| − | <h3>hTERT+tRNA</h3> | + | <h3><strong>New Composite Part</strong> : hTERT+tRNA Composite</h3> |
</div> | </div> | ||
<div class="part_info"> | <div class="part_info"> | ||
| − | <p><a href="http://parts.igem.org/Part:BBa_K1722010"> | + | <p><a href="http://parts.igem.org/Part:BBa_K1722010">BBa_K1722010</a><br> |
hTERT is recognized as a cancer specific promoter for various cancers. The tRNA that is expressed by tRNA gene has CUA as its anticodon, which can pair with the amber mutated stop codon UAG in the mRNA chain to continue the translation of the amber mutated mRNA. Together with BBa_K1722007 and BBa_K1722012, this genetic circuit can specifically recognize bladder cancer cells and express the therapeutic gene out. | hTERT is recognized as a cancer specific promoter for various cancers. The tRNA that is expressed by tRNA gene has CUA as its anticodon, which can pair with the amber mutated stop codon UAG in the mRNA chain to continue the translation of the amber mutated mRNA. Together with BBa_K1722007 and BBa_K1722012, this genetic circuit can specifically recognize bladder cancer cells and express the therapeutic gene out. | ||
</p> | </p> | ||
Revision as of 08:45, 18 September 2015
Composite parts
New Composite Part : SV40+Rluc Composite
BBa_K1722012
SV40 is a strong promoter with enhancer in the upstream. Rluc is a widely used reporter gene which can produce Renilla Luciferase. However, different from normal Rluc reporter gene, this one is being amber mutated and the mRNA chain being transcriped out has a terminator inside it. In this way, the whole chain of Renilla Luciferase cannot be translated in natural condition. Only with two other composite parts of our project (BBa_K1722010& BBa_K1722010) can Renilla Luciferase protein being produced.
New Composite Part : hUPⅡ+AckRS Composite
BBa_K1722007
hUPⅡ is a bladder specific promoter that can only drive gene expression in urothelium cells. As the output gene of this recombinant plasmid, AckRS can produce an RNA synthetase which can achieve the attachment of Ack and tRNA. This composite part will perform its function together with two other plasmids (BBa_K1722010& BBa_K1722012)
New Composite Part : hTERT+tRNA Composite
BBa_K1722010
hTERT is recognized as a cancer specific promoter for various cancers. The tRNA that is expressed by tRNA gene has CUA as its anticodon, which can pair with the amber mutated stop codon UAG in the mRNA chain to continue the translation of the amber mutated mRNA. Together with BBa_K1722007 and BBa_K1722012, this genetic circuit can specifically recognize bladder cancer cells and express the therapeutic gene out.